Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

Our Bureau, New Delhi Thursday, January 15, 2026, 16:30 Hrs [IST] ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Binarly, the industry leader in software and firmware supply-chain security, today announced an upcoming DistrictCon ...

Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...

Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The "Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's offering. An active pharmaceutical ...